Studies with inactivated influenza vaccines purified by zonal centrifugation. 2. Efficacy
- PMID: 5309468
- PMCID: PMC2427700
Studies with inactivated influenza vaccines purified by zonal centrifugation. 2. Efficacy
Abstract
High (3000 CCA units) and standard low (300 CCA units) doses of the monovalent purified vaccines described in an earlier paper were evaluated in a double-blind manner in 2 adult populations for protective effectiveness against illness caused by the Hong Kong influenza virus. Epidemics in both populations occurred 4-6 weeks after single injections of vaccine were given.The attack rates among recipients of low or high doses of A2/Japan vaccines in a prison were virtually identical to those among the control groups receiving B/Massachusetts vaccines. The attack rate among those receiving 3000 CCA units of Aichi vaccine was nearly 70% less than the rate among recipients of A2/Japan or B/Mass. vaccines. Similarly, in a retirement community the attack rate among the recipients of 3000 CCA units of Aichi vaccine was 50%-70% lower than the attack rate among the recipients of the A2/Japan vaccine. In both populations, recipients of high doses of Aichi vaccine who later became ill tended to have less morbidity, fewer and lower fevers, and shorter stays in bed. Attack rates among the groups receiving low doses of Aichi vaccine were somewhat lower than rates among those receiving A2/Japan or B/Mass. vaccines, but the effect was not statistically significant. Divalent and polyvalent commercial vaccines were also without protective effect.The results indicate that optimally constituted influenza vaccines at standard dosage levels have little, if any, effectiveness and that even very large doses of vaccine do not approach the high degrees of effectiveness that have been achieved with other virus vaccines.
Similar articles
-
Studies with inactivated influenza vaccines purified by zonal centrifugation. 1. Adverse reactions and serological responses.Bull World Health Organ. 1969;41(3):525-30. Bull World Health Organ. 1969. PMID: 5309467 Free PMC article.
-
Serological responses and results of natural infectious challenge of recipients of zonal ultracentrifuged influenza A2-Aichi-2-68 vaccine.Bull World Health Organ. 1971;45(6):767-71. Bull World Health Organ. 1971. PMID: 5317012 Free PMC article.
-
Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?Pediatrics. 2006 Sep;118(3):e570-8. doi: 10.1542/peds.2006-0198. Pediatrics. 2006. PMID: 16950948 Clinical Trial.
-
Estimating influenza vaccine efficacy from challenge and community-based study data.Am J Epidemiol. 2008 Dec 15;168(12):1343-52. doi: 10.1093/aje/kwn259. Epub 2008 Oct 29. Am J Epidemiol. 2008. PMID: 18974084 Free PMC article. Review.
-
New vaccine approaches for seasonal and pandemic influenza.Vaccine. 2008 Nov 18;26(49):6232-6. doi: 10.1016/j.vaccine.2008.07.022. Epub 2008 Jul 30. Vaccine. 2008. PMID: 18674583 Review.
Cited by
-
Inactivated influenza vaccines. 2. Laboratory indices of protection.Postgrad Med J. 1973 Mar;49(569):159-63. doi: 10.1136/pgmj.49.569.159. Postgrad Med J. 1973. PMID: 4803439 Free PMC article.
-
Immunogenicity of egg-grown influenza vaccine: inhibition by immunization of recipients with host antigen.Infect Immun. 1972 Jun;5(6):883-9. doi: 10.1128/iai.5.6.883-889.1972. Infect Immun. 1972. PMID: 4635503 Free PMC article.
-
Application of the single radial diffusion test for assay of antibody to influenza type A viruses.J Clin Microbiol. 1975 Dec;2(6):531-40. doi: 10.1128/jcm.2.6.531-540.1975. J Clin Microbiol. 1975. PMID: 812886 Free PMC article.
-
Influenza A neuraminidase antibody assay with sensitized erythrocytes.Appl Microbiol. 1973 Jan;25(1):97-102. doi: 10.1128/am.25.1.97-102.1973. Appl Microbiol. 1973. PMID: 4631440 Free PMC article.
-
Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects.Vaccine. 2007 Nov 1;25(44):7656-63. doi: 10.1016/j.vaccine.2007.08.042. Epub 2007 Sep 14. Vaccine. 2007. PMID: 17913310 Free PMC article. Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical